Professional Documents
Culture Documents
Population Adults with mood and anxiety disorders (post-traumatic stress disorder, generalized anxiety disorder, or
depression)
Intervention Q1, Q4: Neurofeedback provided by a health professional
Q2, Q4: Biofeedback provided by a health professional
Q3, Q4: Biofeedback using home equipment
Comparator Q1-Q3: Other treatmentfor PTSD, GAD, or depression (e.g. cognitive behavior therapy, exposure
therapy, eye moment desensitization reprocessing); or no treatment (waitlist)
Q4: No comparator
Outcomes Q1-Q3: Clinical effectiveness (symptom reduction [e.g. reduced stress, anxiety], safety, quality of life)
Q4: Evidence-based guidelines
Study Health technology assessments, systematic reviews, meta-analyses, randomized controlled trials, non-
Designs randomized studies, and evidence-based guidelines
From: Neurofeedback and Biofeedback for Mood and Anxiety Disorders: A Review of Clinical Effectiveness and Guidelines
Neurofeedback and Biofeedback for Mood and Anxiety Disorders: A Review of Clinical
Effectiveness and Guidelines [Internet].
Banerjee S, Argáez C.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Nov 13.
Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
https://www.ncbi.nlm.nih.gov/books/NBK531603/table/table1/?report=objectonly 1/1